{"id":683,"date":"2014-06-19T17:02:59","date_gmt":"2014-06-19T17:02:59","guid":{"rendered":"http:\/\/ingelyt.com\/?page_id=31"},"modified":"2014-08-26T10:52:46","modified_gmt":"2014-08-26T10:52:46","slug":"legislacion","status":"publish","type":"page","link":"https:\/\/ingelyt.com\/en\/regulation-and-legislation","title":{"rendered":"Regulation and legislation"},"content":{"rendered":"<p>Most relevant regulations for biomedical sector are included (Pharmaceutical, Veterinary, Biosecurity, Cosmetic or sanitary producs) in order to accomplish the requirements in a facility, project or production process. In case of being interested in having more details of the current legislation in a sector or having doubts for the proper interpretation do not hesitate to contact us we will help you: pharmasupport@ingelyt.com<br \/>\nWe can also help bring your project to the most important regulatory agencies (AEMPS, EMA, FDA, Anvisa or any regulatory agency) for review and approval or clear any doubts about the regulatory agencies before or during the project.<br \/>\nWe ensure that projects designed and implemented by Ingelyt conform to the current regulation in order for the facilities to be approved by different regulatory agencies for higher requirements markets, being able to perform all required documentation for its approval (technical report, Site Master File (SMF), qualifications of facilities and equipment, pharmaceutical plans, risk analysis, process validation protocols, simulation aseptic protocols (Media Fill), &#8230;.)<\/p>\n<ol class=\"big\">\n<li><span style=\"color: #3366ff\"><strong>Good Manufacturing Practices (GMP)<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff\"><strong>Pharmaceutical Legislation<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff\"><strong>Steril product legislation<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff\"><strong>Cosmetic product legislation<\/strong><\/span><\/li>\n<li><span style=\"color: #3366ff\"><strong>Biosecurity<\/strong><\/span><\/li>\n<\/ol>\n<h2 id=\"unos\">1. Good Manufacturing Practices (GMP)<\/h2>\n<p>Good Manufacturing Practices (GMP) are the basic guidelines for defining quality standards in medicines manufaction. They are mandatory for the pharmaceutical industry.<\/p>\n<ul class=\"lower-alpha\">\n<li><strong>Europa (European Medicine Agency)(EMA)<\/strong>\n<ul>\n<li>Good Manufacturing Practices AEMPS (Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios)<br \/>\nGood manufacturing practices of AEMPS is the transposition of European current legislation.<br \/>\n<a href=\"http:\/\/www.aemps.gob.es\/industria\/inspeccionNCF\/guiaNCF\/home.htm\" target=\"_blank\">http:\/\/www.aemps.gob.es\/industria\/inspeccionNCF\/guiaNCF\/home.htm<\/a><\/li>\n<li>Normas de correcta fabricaci\u00f3n EMA (European Medicine Agency)<\/li>\n<li>EudraLex &#8211; Volume 4 Good manufacturing practice (GMP) Guidelines (EMA)<\/li>\n<li>Good manufacturing practices common to all EU countries<br \/>\n<a href=\"http:\/\/ec.europa.eu\/health\/documents\/eudralex\/vol-4\/index_en.htm\" target=\"_blank\">http:\/\/ec.europa.eu\/health\/documents\/eudralex\/vol-4\/index_en.htm<\/a><\/li>\n<\/ul>\n<\/li>\n<li><strong>United States (Food Drug administration) (FDA)<\/strong>\n<ul>\n<li>21 Code of Federal Regulations Part 210.\u00a0 Current Good Manufacturing Practice in Manufacturing Processing, packing, or Holding of Drugs<br \/>\n<a href=\"http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=210.1\" target=\"_blank\">http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=210.1<\/a><\/li>\n<li>21 Code of Federal Regulations Part 211.\u00a0 Current Good Manufacturing Practice for Finished Pharmaceuticals<br \/>\n<a href=\"http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=211\" target=\"_blank\">http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=211<\/a><\/li>\n<\/ul>\n<\/li>\n<li><strong>World health organization (WHO)<\/strong>\n<ul>\n<li><a href=\"http:\/\/www.who.int\/medicines\/areas\/quality_safety\/quality_assurance\/GMPPharmaceuticalProductsMainPrinciplesTRS961Annex3.pdf?ua=1\" target=\"_blank\">http:\/\/www.who.int\/medicines\/areas\/quality_safety\/quality_assurance\/GMPPharmaceuticalProductsMainPrinciplesTRS961Annex3.pdf?ua=1<\/a><\/li>\n<\/ul>\n<\/li>\n<li><strong>PIC\/S (Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme )<\/strong>\n<ul>\n<li>PIC\/S GMP Guide<a href=\"http:\/\/www.picscheme.org\/publication.php?id=4\" target=\"_blank\">http:\/\/www.picscheme.org\/publication.php?id=4<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2 id=\"dos\">2. 2. Pharmaceutical legislation<\/h2>\n<p>More relevant pharmaceutical international regulation in order to meet international requirements in facilities and manufacture of medicines<\/p>\n<ul class=\"lower-alpha\">\n<li><strong>ICH (International Conference harmonization)<\/strong><br \/>\nThe ICH (International Conference Harmonization) guidelines are standardized rules among the most important regulatory agencies (Europe, FDA and Japan) in order to guarantee common quality standards.<\/p>\n<ul>\n<li>Q7 Good manufacturing practice guide for active pharmaceutical ingredients<br \/>\n<a href=\"http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q7\/Step4\/Q7_Guideline.pdf\" target=\"_blank\">http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q7\/Step4\/Q7_Guideline.pdf<\/a><\/li>\n<li>Q9 Quality risk management<br \/>\n<a href=\"http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q9\/Step4\/Q9_Guideline.pdf\" target=\"_blank\">http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q9\/Step4\/Q9_Guideline.pdf<\/a><\/li>\n<\/ul>\n<\/li>\n<li><strong>PIC\/S (Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme)<\/strong>\n<ul>\n<li><a href=\"http:\/\/www.picscheme.org\/publication.php?id=4\" target=\"_blank\">http:\/\/www.picscheme.org\/publication.php?id=4<\/a><\/li>\n<li>Explanatory notes for pharmaceutical manufacturers on the preparation of a site master file PE 008-4<\/li>\n<li>Validation master plan installation and operational qualification non-sterile process<\/li>\n<li>Validation cleaning validation PI 006-3<\/li>\n<li>Validation of aseptic processes PI 007-6<\/li>\n<\/ul>\n<\/li>\n<li><strong>World health organization (WHO)<\/strong>\n<ul>\n<li>Inspections guidelines<br \/>\n<a href=\"http:\/\/www.who.int\/medicines\/areas\/quality_safety\/quality_assurance\/inspections\/en\" target=\"_blank\">http:\/\/www.who.int\/medicines\/areas\/quality_safety\/quality_assurance\/inspections\/en<\/a><\/li>\n<li>Production guidelines<br \/>\n<a href=\"http:\/\/www.who.int\/medicines\/areas\/quality_safety\/quality_assurance\/production\/en\/\" target=\"_blank\">http:\/\/www.who.int\/medicines\/areas\/quality_safety\/quality_assurance\/production\/en\/<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2 id=\"tres\">Steril products legislation<\/h2>\n<p>Sterile products as the risk that they suppose for the final user, have a specific regulation that must be met by the different manufacturers.<\/p>\n<p>The most relevant pharmaceutical international Regulations in order to meet international requirements in manufacture of sterile products.<\/p>\n<ul class=\"circle\">\n<li><strong>Eudralex Vol. 4 (EU GMP) Annex 1 \u201cGuideline for the manufacture of sterile medicine products.\u201d<\/strong><br \/>\n<a href=\"http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-4\/2008_11_25_gmp-an1_en.pdf\" target=\"_blank\">http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-4\/2008_11_25_gmp-an1_en.pdf<\/a><\/li>\n<li><strong>PICS PI007-6 Recommendation on the validation of septic processes<\/strong><br \/>\n<a href=\"http:\/\/www.picscheme.org\/pdf\/26_pi007-6recommendationonasepticprocesses.pdf\" target=\"_blank\">http:\/\/www.picscheme.org\/pdf\/26_pi007-6recommendationonasepticprocesses.pdf<\/a><\/li>\n<li><strong>FDA Guidance sterile drug products produced by aseptic processes<\/strong><br \/>\n<a href=\"http:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/ucm070342.pdf\" target=\"_blank\">http:\/\/www.fda.gov\/downloads\/Drugs\/&#8230;\/Guidances\/ucm070342.pdf<\/a><\/li>\n<li><strong>ISO13408 Aseptic processing of health care products general requeriments<\/strong><br \/>\n<a href=\"http:\/\/www.iso.org\/iso\/search.htm?qt=13408&amp;sort_by=rel&amp;type=simple&amp;published=on&amp;active_tab=standards\" target=\"_blank\">http:\/\/www.iso.org\/iso\/search.htm?qt=13408&amp;sort_by=rel&amp;type=simple&amp;published=on&amp;active_tab=standards<\/a><\/li>\n<li><strong>PDA TR N\u00ba 28 : process simulation testing for sterile bulk pharmaceutical chemicals <\/strong><br \/>\n<a href=\"https:\/\/store.pda.org\/TableOfContents\/PDA_Technical_Reports_list.pdf\" target=\"_blank\">https:\/\/store.pda.org\/TableOfContents\/PDA_Technical_Reports_list.pdf<\/a><\/li>\n<li><strong>PDA TR N\u00ba44 : Quality risk management for aseptic processes (2008)<\/strong><br \/>\n<a href=\"https:\/\/store.pda.org\/TableOfContents\/PDA_Technical_Reports_list.pdf\" target=\"_blank\">https:\/\/store.pda.org\/TableOfContents\/PDA_Technical_Reports_list.pdf<\/a><\/li>\n<li><strong>PDA TR N\u00ba22 Process simulation for aseptically filled products (2011)<\/strong><br \/>\n<a href=\"https:\/\/store.pda.org\/TableOfContents\/PDA_Technical_Reports_list.pdf\" target=\"_blank\">https:\/\/store.pda.org\/TableOfContents\/PDA_Technical_Reports_list.pdf<\/a><\/li>\n<li><strong>PDA TR N62 : Recommended practices for manual aseptic processes<\/strong><br \/>\n<a href=\"https:\/\/store.pda.org\/TableOfContents\/PDA_Technical_Reports_list.pdf\" target=\"_blank\">https:\/\/store.pda.org\/TableOfContents\/PDA_Technical_Reports_list.pdf<\/a><\/li>\n<\/ul>\n<h3 id=\"cuatro\">Cosmetic products legislation<\/h3>\n<p>Manufacture of cosmetic products has a specific legislation for the facilities and manufacturing processes of cosmetic products.<\/p>\n<ul class=\"circle\">\n<li><strong>Guides FDA relative to manufacture of cosmetics<\/strong><br \/>\n<a href=\"http:\/\/www.fda.gov\/Cosmetics\/GuidanceRegulation\/GuidanceDocuments\/default.htm\" target=\"_blank\">http:\/\/www.fda.gov\/Cosmetics\/GuidanceRegulation\/GuidanceDocuments\/default.htm<\/a><\/li>\n<li><strong>Regulation (EC) No 1223\/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products<\/strong><br \/>\n<a href=\"http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:EN:PDF\" target=\"_blank\">http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:EN:PDF<\/a><\/li>\n<li><strong>ISO 22716:2007 Cosmetics GMP<\/strong><br \/>\n<a href=\"http:\/\/www.iso.org\/iso\/catalogue_detail.htm?csnumber=36437\" target=\"_blank\">http:\/\/www.iso.org\/iso\/catalogue_detail.htm?csnumber=36437<\/a><\/li>\n<\/ul>\n<h2 id=\"cinco\">Biosecurity<\/h2>\n<p>The manipulation of living microorganisms needs a few specific requirements in the facilities destined for their manipulation shuch as investigation centers or manufacturers laboratories of biological origin medicines.<\/p>\n<ul class=\"circle\">\n<li><strong>Technical Guide for the evaluation and prevention of risks associated with exposure to biological agents (INSHT del Ministerio de Trabajo)\/strong&gt;<br \/>\n<a href=\"http:\/\/www.insht.es\/InshtWeb\/Contenidos\/Normativa\/GuiasTecnicas\/Ficheros\/agen_bio.pdf\" target=\"_blank\">http:\/\/www.insht.es\/InshtWeb\/Contenidos\/Normativa\/GuiasTecnicas\/Ficheros\/agen_bio.pdf<\/a><\/strong><\/li>\n<li><strong>Regulations of the CDC (Centers for disease control and prevention) of the United States of America (USA) concerning levels of control for different levels of biosecurity<\/strong><br \/>\n<a href=\"http:\/\/www.cdc.gov\/biosafety\/publications\/bmbl5\/bmbl5_sect_iv.pdf\" target=\"_blank\">http:\/\/www.cdc.gov\/biosafety\/publications\/bmbl5\/bmbl5_sect_iv.pdf<\/a><\/li>\n<li><strong>Canadian regulations (Laboratory Biosafety Guidelines)<\/strong><br \/>\n<a href=\"http:\/\/www.phac-aspc.gc.ca\/publicat\/lbg-ldmbl-04\/index-eng.php\" target=\"_blank\">http:\/\/www.phac-aspc.gc.ca\/publicat\/lbg-ldmbl-04\/index-eng.php<\/a><\/li>\n<li><strong>Biosafety Guidelines of the World Health Organization (WHO), 2003<\/strong><br \/>\n<a href=\"http:\/\/www.who.int\/csr\/resources\/publications\/biosafety\/CDS_CSR_LYO_2004_11SP.pdf\" target=\"_blank\">http:\/\/www.who.int\/csr\/resources\/publications\/biosafety\/CDS_CSR_LYO_2004_11SP.pdf<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Most relevant regulations for biomedical sector are included (Pharmaceutical, Veterinary, Biosecurity, Cosmetic or sanitary producs) in order to accomplish the requirements in a facility, project or production process. In case of being interested in having more details of the current [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":1219,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"legislacion.php","meta":{"footnotes":""},"class_list":["post-683","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Regulation and legislation - Clean rooms engineering - Ingelyt - Engineering and installations<\/title>\n<meta name=\"description\" content=\"At Ingelyt we are high qualificated proffessionals with a large experience in Regulation and legislation for the engineering and installation of clean rooms and pharmaceutical consultancy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regulation and legislation - Clean rooms engineering - Ingelyt - Engineering and installations\" \/>\n<meta property=\"og:description\" content=\"At Ingelyt we are high qualificated proffessionals with a large experience in Regulation and legislation for the engineering and installation of clean rooms and pharmaceutical consultancy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/\" \/>\n<meta property=\"og:site_name\" content=\"Ingelyt - Engineering and installations\" \/>\n<meta property=\"article:modified_time\" content=\"2014-08-26T10:52:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ingelyt.com\/en\/wp-content\/uploads\/sites\/2\/2014\/06\/legislacion.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"334\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/\",\"url\":\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/\",\"name\":\"Regulation and legislation - Clean rooms engineering - Ingelyt - Engineering and installations\",\"isPartOf\":{\"@id\":\"https:\/\/ingelyt.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ingelyt.com\/en\/wp-content\/uploads\/sites\/2\/2014\/06\/legislacion.jpg\",\"datePublished\":\"2014-06-19T17:02:59+00:00\",\"dateModified\":\"2014-08-26T10:52:46+00:00\",\"description\":\"At Ingelyt we are high qualificated proffessionals with a large experience in Regulation and legislation for the engineering and installation of clean rooms and pharmaceutical consultancy.\",\"breadcrumb\":{\"@id\":\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#primaryimage\",\"url\":\"https:\/\/ingelyt.com\/en\/wp-content\/uploads\/sites\/2\/2014\/06\/legislacion.jpg\",\"contentUrl\":\"https:\/\/ingelyt.com\/en\/wp-content\/uploads\/sites\/2\/2014\/06\/legislacion.jpg\",\"width\":500,\"height\":334},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ingelyt.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regulation and legislation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ingelyt.com\/en\/#website\",\"url\":\"https:\/\/ingelyt.com\/en\/\",\"name\":\"Ingelyt - Engineering and installations\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ingelyt.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regulation and legislation - Clean rooms engineering - Ingelyt - Engineering and installations","description":"At Ingelyt we are high qualificated proffessionals with a large experience in Regulation and legislation for the engineering and installation of clean rooms and pharmaceutical consultancy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/","og_locale":"en_US","og_type":"article","og_title":"Regulation and legislation - Clean rooms engineering - Ingelyt - Engineering and installations","og_description":"At Ingelyt we are high qualificated proffessionals with a large experience in Regulation and legislation for the engineering and installation of clean rooms and pharmaceutical consultancy.","og_url":"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/","og_site_name":"Ingelyt - Engineering and installations","article_modified_time":"2014-08-26T10:52:46+00:00","og_image":[{"width":500,"height":334,"url":"https:\/\/ingelyt.com\/en\/wp-content\/uploads\/sites\/2\/2014\/06\/legislacion.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/","url":"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/","name":"Regulation and legislation - Clean rooms engineering - Ingelyt - Engineering and installations","isPartOf":{"@id":"https:\/\/ingelyt.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#primaryimage"},"image":{"@id":"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#primaryimage"},"thumbnailUrl":"https:\/\/ingelyt.com\/en\/wp-content\/uploads\/sites\/2\/2014\/06\/legislacion.jpg","datePublished":"2014-06-19T17:02:59+00:00","dateModified":"2014-08-26T10:52:46+00:00","description":"At Ingelyt we are high qualificated proffessionals with a large experience in Regulation and legislation for the engineering and installation of clean rooms and pharmaceutical consultancy.","breadcrumb":{"@id":"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ingelyt.com\/en\/regulation-and-legislation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#primaryimage","url":"https:\/\/ingelyt.com\/en\/wp-content\/uploads\/sites\/2\/2014\/06\/legislacion.jpg","contentUrl":"https:\/\/ingelyt.com\/en\/wp-content\/uploads\/sites\/2\/2014\/06\/legislacion.jpg","width":500,"height":334},{"@type":"BreadcrumbList","@id":"https:\/\/ingelyt.com\/en\/regulation-and-legislation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ingelyt.com\/en\/"},{"@type":"ListItem","position":2,"name":"Regulation and legislation"}]},{"@type":"WebSite","@id":"https:\/\/ingelyt.com\/en\/#website","url":"https:\/\/ingelyt.com\/en\/","name":"Ingelyt - Engineering and installations","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ingelyt.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/ingelyt.com\/en\/wp-json\/wp\/v2\/pages\/683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ingelyt.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ingelyt.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ingelyt.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ingelyt.com\/en\/wp-json\/wp\/v2\/comments?post=683"}],"version-history":[{"count":6,"href":"https:\/\/ingelyt.com\/en\/wp-json\/wp\/v2\/pages\/683\/revisions"}],"predecessor-version":[{"id":1576,"href":"https:\/\/ingelyt.com\/en\/wp-json\/wp\/v2\/pages\/683\/revisions\/1576"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ingelyt.com\/en\/wp-json\/wp\/v2\/media\/1219"}],"wp:attachment":[{"href":"https:\/\/ingelyt.com\/en\/wp-json\/wp\/v2\/media?parent=683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}